Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

This journal has not published any issues.

Impact Factor 2025

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

PO007 | OUTCOMES OF PATIENTS WITH JAK2V617F VAF ≤2% EVALUATED FOR SUSPECTED MYELOPROLIFERATIVE NEOPLASMS E. Morsia, F. Saladino, R. Ceccarelli, L. Gurgoglione, A. Poloni | Università Politecnica delle Marche, Italy

Erika Morsia

26-10-2026

https://doi.org/10.4081/btvb.2026.823

0

PDF: 0
PO048 | EFFICACY OF RITUXIMAB TREATMENT IN A CASE OF A RELAPSED AND REFRACTORY ACQUIRED VON WILLEBRAND DISEASE SECONDARY TO PRIMARY CUTANEOUS MARGINAL ZONE B-CELL LYMPHOMA L. Gurgoglione¹, F. Saladino², E. Morsia², N. Viola³, S. Rupoli¹, A. Poloni² | ¹Clinical Hematology, AOU delle Marche, Ancona, Italy; ²Università Politecnica delle Marche, Ancona, Italy; ³Clinical Immulogy, AOU delle Marche, Ancona, Italy

Laura Gurgoglione

26-10-2026

https://doi.org/10.4081/btvb.2026.864

0

PDF: 0

1 - 2 of 2 items

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.